|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.57 USD | +12.57% |
|
+24.59% | +259.10% |
| 08-06 | 10x Genomics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | (TXG) 10x Genomics Now Expects 2026 Revenue Range $610M-$630M, vs. FactSet Est of $613.7M | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 59.54 | 77.25 | 62.91 |
| Spread/Res. | -1.63% | -24.18% | -6.90% |
| Spread/Supp. | +27.55% | +103.09% | +124.58% |
| Support | 45.92 | 28.84 | 26.08 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- TXG Stock
- Charts 10x Genomics, Inc.
Select your edition
All financial news and data tailored to specific country editions
